Comparative evaluation of platelet-rich fibrin biomaterial and open flap debridement in the treatment of two and three wall intrabony defects.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4409793)

Published in J Int Oral Health on April 01, 2015

Authors

Himanshu Ajwani1, Sharath Shetty2, Dharmarajan Gopalakrishnan3, Rahul Kathariya4, Anita Kulloli5, R S Dolas6, A R Pradeep7

Author Affiliations

1: Past Post Graduate Student, Department of Periodontology & Oral Implantology, Dr. D.Y. Patil Dental College & Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
2: Associate Professor, Department of Periodontology & Oral Implantology, Dr. D.Y. Patil Dental College & Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
3: Professor & Head, Department of Periodontology & Oral Implantology, Dr. D.Y. Patil Dental College & Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
4: Assistant Professor, Department of Periodontology & Oral Implantology, Dr. D.Y. Patil Dental College & Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
5: Professor, Department of Periodontology & Oral Implantology, Dr. D.Y. Patil Dental College & Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
6: Former Dean & Professor, Department of Oral & Maxillofacial Surgery, Dr. D.Y. Patil Dental College & Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.
7: Professor and Head, Department of Periodontology & Oral Implantology, Government Dental College and Research Institute, Bengaluru, Karnataka, India.

Associated clinical trials:

Advanced Platelet Rich Fibrin in Periodontal Angular Defects | NCT03433066

Articles cited by this

Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study. J Periodontol (2009) 2.45

Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors (2009) 1.75

Autologous platelet-rich fibrin in the treatment of mandibular degree II furcation defects: a randomized clinical trial. J Periodontol (2011) 1.69

Fibroblast migration in fibrin gel matrices. Am J Pathol (1993) 1.64

Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol (2010) 1.59

Treatment of 3-wall intrabony defects in patients with chronic periodontitis with autologous platelet-rich fibrin: a randomized controlled clinical trial. J Periodontol (2011) 1.49

Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol (2009) 1.31

Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial. J Periodontol (2012) 1.31

Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol (2012) 1.27

Biology and principles of periodontal wound healing/regeneration. Periodontol 2000 (2006) 1.27

Platelet-rich fibrin membranes as scaffolds for periosteal tissue engineering. Clin Oral Implants Res (2010) 1.20

Leukocyte- and platelet-rich fibrin (L-PRF) for long-term delivery of growth factor in rotator cuff repair: review, preliminary results and future directions. Curr Pharm Biotechnol (2012) 1.07

Goals of periodontal therapy. J Periodontol (1976) 0.99

Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results. J Periodontol (2000) 0.99

Outcome variables for the study of periodontal regeneration. Ann Periodontol (1997) 0.98

Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol (1996) 0.97

Effects of platelet rich fibrin alone used with rigid titanium barrier. Arch Oral Biol (2012) 0.94

Clinical effectiveness of autologous platelet-rich plasma and Peptide-enhanced bone graft in the treatment of intrabony defects. J Periodontol (2009) 0.92

Healing of periodontal lesions in monkeys following the guided tissue regeneration procedure. A histological study. J Clin Periodontol (1995) 0.90

Defect-determined regenerative options for treating periodontal intrabony defects in baboons. J Periodontol (2003) 0.88

Regenerative effect of basic fibroblast growth factor on periodontal healing in two-wall intrabony defects in dogs. J Clin Periodontol (2010) 0.87

Iliac transplants in periodontal therapy. J Periodontol (1970) 0.84

Retrospective analysis of factors related to clinical outcome of guided tissue regeneration procedures in intrabony defects. J Clin Periodontol (1997) 0.83

Evaluation of an injectable rhGDF-5/PLGA construct for minimally invasive periodontal regenerative procedures: a histological study in the dog. J Clin Periodontol (2010) 0.83

Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial. J Periodontol (2010) 0.82

Comparison of clinical outcomes following guided tissue regeneration treatment with a polylactic acid barrier or a collagen membrane. Int J Periodontics Restorative Dent (2010) 0.81

Relevance of Choukroun's Platelet-Rich Fibrin (PRF) and SMAS flap in primary reconstruction after superficial or subtotal parotidectomy in patients with focal pleiomorphic adenoma: a new technique. Rev Laryngol Otol Rhinol (Bord) (2008) 0.80